Sacituzumab Govitecan in Metastatic Breast Cancer. Reply
- PMID: 34260848
- DOI: 10.1056/NEJMc2108478
Sacituzumab Govitecan in Metastatic Breast Cancer. Reply
Comment on
-
Sacituzumab Govitecan in Metastatic Breast Cancer.N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478. N Engl J Med. 2021. PMID: 34260847 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical